Clinical Trials · NCT06519656

Efficacy of Mazdutide for Treating PCOS

CompletedPhase 1/Phase 2Mazdutide (Approved)
Phase
Phase 1/Phase 2
Recruitment status
Completed
Sponsor
Shanghai Zhongshan Hospital
Enrollment
43
Start date
Oct 2024
Locations
1 site, China
Primary endpoint
Free Androgen Index (FAI)
View Mazdutide compound reference